Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice Notified -
FloQast Introduces New AI Accounting Innovations at TakeControl 2026 and Names COSO Chair Lucia Wind as SVP of Risk & Audit Advisory Notified -
Mavenir Launches NetAIShield: AI-Native Fraud Protection for Voice, Messaging and Data Operator Services Notified -
Venionaire Capital strengthens Southeast Asia presence with Lukas Naujack as Associate Partner Notified -
Schneider Electric finds AI-enabled buildings can cut energy use by up to 22%, save on annual utility costs and carbon Notified -
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients Notified -
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs Notified -
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults Notified -